WuXi XDC Cayman Inc
2268
주식 순위
#1886
WuXi XDC Cayman Inc. operates as an investment holding company and a global... WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
주가
$8.78
시가총액
$11.12B
변동 (1일)
-9.52%
변동 (1년)
0.57%
국가
CN
거래 WuXi XDC Cayman Inc (2268)
카테고리
Healthcare
WuXi XDC Cayman Inc (2268)의 P/B 비율
October 2026 기준 P/B 비율 TTM: 6.53
WuXi XDC Cayman Inc의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 6.53입니다. 2024년 말 기준 P/B 비율은 5.20였습니다.
WuXi XDC Cayman Inc의 P/B 비율 기록 (2020 ~ 2026)
매년 말 P/B 비율
| 연도 | P/B 비율 | 변화 |
|---|---|---|
| 2026 (TTM) | 6.53 | -2.87% |
| 2025 | 6.72 | 29.37% |
| 2024 | 5.20 | -10.37% |
| 2023 | 5.80 | -70.54% |
| 2022 | 19.68 | -98.47% |
| 2021 | 1.29K | 1,641.63% |
| 2020 | 73.89 | 0.00% |
유사 기업 또는 경쟁사의 P/B 비율
| 회사 | P/B 비율 | P/B 비율 차이 | 국가 |
|---|---|---|---|
| 4.7411 | -27.36% |
US
|
|
| 3.0143 | -53.82% |
US
|
|
| 31.051 | 375.74% |
US
|
|
| 4.9326 | -24.43% |
CN
|
|
| 6.8081 | 4.31% |
US
|
